Login / Signup

Final analysis of a randomized phase II/III trial of conventional paclitaxel and carboplatin with or without bevacizumab versus dose-dense paclitaxel and carboplatin with or without bevacizumab, in stage IVB, recurrent, or persistent cervical carcinoma (JCOG1311).

Mitsuya IshikawaTaro ShibataTomoko KataokaMunetaka TakekumaHiroaki KobayashiNobuo YaegashiToyomi Satohnull null
Published in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
jRCTs031180007.
Keyphrases
  • phase iii
  • phase ii
  • open label
  • clinical trial
  • phase ii study
  • metastatic colorectal cancer
  • placebo controlled
  • double blind
  • study protocol
  • chemotherapy induced
  • randomized controlled trial
  • squamous cell carcinoma